<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02469454</url>
  </required_header>
  <id_info>
    <org_study_id>ENG-implant-02</org_study_id>
    <nct_id>NCT02469454</nct_id>
  </id_info>
  <brief_title>Effect of t of the Etonogestrel Releasing Implant on Infant Growth and Development</brief_title>
  <official_title>Effect of the Immediately Postpartum Insertion of the Etonogestrel Releasing Implant on Infant Growth and Development</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to assess whether there is change in the growth and development of newborns
      whose mothers will have a etonogestrel (ENG) releasing implant inserted in the first 24 to 48
      hours of delivery compared with those with standard implant insertion (6 week postpartum).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>neonatal growth</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>child development</measure>
    <time_frame>12 months</time_frame>
    <description>Child development will be evaluated by Bayley III Scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Contraception</condition>
  <condition>Newborn</condition>
  <condition>Child Development</condition>
  <condition>Growth</condition>
  <arm_group>
    <arm_group_label>early insertion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Postpartum women into whom the etonogestrel-releasing contraceptive implant (Implanon®, N.V. Organon, Oss, Netherlands) will be inserted in the first 48 h postpartum. The ENG implant will be inserted subdermally in the non-dominant arm of volunteers upon local anesthesia with 2% lidocaine with vasoconstrictor, according to the manufacturer's instructions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional insertion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Postpartum women into whom the etonogestrel-releasing contraceptive implant (Implanon®, N.V. Organon, Oss, Netherlands) will be inserted after 6 week of the delivery. The ENG implant will be inserted subdermally in the non-dominant arm of volunteers upon local anesthesia with 2% lidocaine with vasoconstrictor, according to the manufacturer's instructions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>early insertion</intervention_name>
    <description>Postpartum women into whom the etonogestrel-releasing contraceptive implant (Implanon®, N.V. Organon, Oss, Netherlands) will be inserted in the first 48 h postpartum.</description>
    <arm_group_label>early insertion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>conventional insertion</intervention_name>
    <description>Postpartum women into whom the etonogestrel-releasing contraceptive implant (Implanon®, N.V. Organon, Oss, Netherlands) will be inserted in the first 6 week of delivery.</description>
    <arm_group_label>conventional insertion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women who desire to use the ENG implant as a contraceptive method and desire to
             breastfeed her newborn for ate least 3 months;

          -  With no contraindication to breastfeeding, whose newborn is healthy, without
             malformations, born at term (gestational age ≥ 37 weeks), with appropriate weight for
             gestational age and with normal sucking ability

        Exclusion Criteria:

          -  Tobacco smokers, drug addicts or alcoholics;

          -  Women with educational levels lower than 5 years;

          -  Women with clinical conditions considered category 3 and 4 for implant use by the WHO;

          -  Women with histories of psychiatric illness;

          -  Women using medications that could alter the concentration of ENG,

          -  Women with known allergies to the local anesthetic lidocaine (used to place the
             implant);

          -  Women who wanted to keep their cyclic menstrual bleeding
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carolina S Vieira, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sao Paulo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Hospital of Sao Paulo University</name>
      <address>
        <city>Ribeirao Preto</city>
        <state>SP</state>
        <zip>14048900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2015</study_first_submitted>
  <study_first_submitted_qc>June 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2015</study_first_posted>
  <last_update_submitted>November 2, 2016</last_update_submitted>
  <last_update_submitted_qc>November 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Carolina Sales Vieira</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>etonogestrel-implant</keyword>
  <keyword>newborn</keyword>
  <keyword>growth</keyword>
  <keyword>Child Development</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Contraceptive Agents</mesh_term>
    <mesh_term>Etonogestrel</mesh_term>
    <mesh_term>Desogestrel</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

